Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Devilee

Showing results (11-20 of 282) with videos related to

Pageof 29
Sort By:
The Journal of Pathology|April 9, 2005
Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotypeMarjo van Puijenbroek, Christi J van Asperen, Anneke van Mil, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 25, 2026
Pilot study: transduction of primary paraganglioma chromaffin tumour cells with inducible c-MYC drives cell proliferationJuan Zhang, Heggert G Rebel, Dominique Duesman, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|May 30, 2009
BRCA2 heterozygosity delays cytokinesis in primary human fibroblastsAsta Björk Jonsdottir, Maaike P G Vreeswijk, Ron Wolterbeek, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 7, 2007
Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohortCatharina E Jacobi, Yvette van Ierland, Christi J van Asperen, et al.
Carcinogenesis|May 8, 2009
5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse modelPim J Koelink, Els C Robanus-Maandag, Peter Devilee, et al.
Cancer|July 28, 2005
Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinomaEwa Joanna Majdak, Jaroslaw Debniak, Tomasz Milczek, et al.
Breast Care (Basel, Switzerland)|October 4, 2021
Survey on Physicians' Knowledge and Training Needs in Genetic Counseling in GermanyJulia Dick, Viktoria Aue, Simone Wesselmann, et al.
Breast Cancer Research and Treatment|July 9, 2010
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGHSimon A Joosse, Kim I M Brandwijk, Peter Devilee, et al.
Plos One|September 30, 2022
Long-term in vitro 2D-culture of SDHB and SDHD-related human paragangliomas and pheochromocytomasJean-Pierre Bayley, Heggert G Rebel, Kimberly Scheurwater, et al.
Journal of Medical Genetics|November 9, 2021
<i>SDHB</i> variant type impacts phenotype and malignancy in pheochromocytoma-paragangliomaJean Pierre Bayley, Birke Bausch, Jeroen C Jansen, et al.
Pageof 29

Showing results (11-20 of 282) with videos related to

Sort By:
Pageof 29
The Journal of Pathology|April 9, 2005
Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotypeMarjo van Puijenbroek, Christi J van Asperen, Anneke van Mil, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 25, 2026
Pilot study: transduction of primary paraganglioma chromaffin tumour cells with inducible c-MYC drives cell proliferationJuan Zhang, Heggert G Rebel, Dominique Duesman, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|May 30, 2009
BRCA2 heterozygosity delays cytokinesis in primary human fibroblastsAsta Björk Jonsdottir, Maaike P G Vreeswijk, Ron Wolterbeek, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 7, 2007
Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohortCatharina E Jacobi, Yvette van Ierland, Christi J van Asperen, et al.
Carcinogenesis|May 8, 2009
5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse modelPim J Koelink, Els C Robanus-Maandag, Peter Devilee, et al.
Cancer|July 28, 2005
Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinomaEwa Joanna Majdak, Jaroslaw Debniak, Tomasz Milczek, et al.
Breast Care (Basel, Switzerland)|October 4, 2021
Survey on Physicians' Knowledge and Training Needs in Genetic Counseling in GermanyJulia Dick, Viktoria Aue, Simone Wesselmann, et al.
Breast Cancer Research and Treatment|July 9, 2010
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGHSimon A Joosse, Kim I M Brandwijk, Peter Devilee, et al.
Plos One|September 30, 2022
Long-term in vitro 2D-culture of SDHB and SDHD-related human paragangliomas and pheochromocytomasJean-Pierre Bayley, Heggert G Rebel, Kimberly Scheurwater, et al.
Journal of Medical Genetics|November 9, 2021
<i>SDHB</i> variant type impacts phenotype and malignancy in pheochromocytoma-paragangliomaJean Pierre Bayley, Birke Bausch, Jeroen C Jansen, et al.
Pageof 29